Helping You Build Wealth With Honest Research
Since 1996. Read On...

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

Suven Life Sciences Plunges 4%; BSE HEALTHCARE Index Up 1.0%
Wed, 28 Aug 15:6

Suven Life Sciences Plunges 4%; BSE HEALTHCARE Index Up 1.0%Image source: CreativaImages/www.istockphoto.com

Suven Life Sciences share price has plunged 4% and is presently trading at Rs 148.6.

Meanwhile, the BSE HEALTHCARE index is at 42,762.4 (up 1.0%).

Among the top losers in the BSE HEALTHCARE index today are CAPLIN POINT (down 4.4%) and GSK Pharma (down 2.1%).

GRANULES INDIA (up 4.5%) and AJANTA PHARMA (up 3.4%) are among the top gainers today.

Over the last one year, Suven Life Sciences has moved up from Rs 65.4 to Rs 148.6, registering a gain of Rs 83.2 (up 127.2%).

On the other hand, the BSE HEALTHCARE index has moved up from 27,859.6 to 42,762.4, registering a gain of 53.5% during the last 12 months.

The top gainers among the BSE HEALTHCARE index stocks during this same period were GRANULES INDIA (up 135.5%), Glenmark Pharma (up 122.7%) and SUVEN PHARMACEUTICALS (up 106.6%).

Must See: These Segments are Witnessing Incredible Growth with Modi's Push

What About the Benchmark Indices?

The BSE Sensex is at 81,810.1 (up 0.1%).

The top gainers among the BSE Sensex today are Indusind Bank (up 2.5%) and Bharti Airtel (up 2.2%). The most traded stocks in the BSE Sensex are Tata Steel and NTPC.

In the meantime, NSE Nifty is at 25,057.2 (up 0.2%). LTIMINDTREE and Wipro are among the top gainers in NSE NIFTY.

Over the last 12 months, the BSE Sensex has moved up from 64,996.6 to 81,810.1, registering a gain of 16,813.5 points (up 25.9%).

Suven Life Sciences Financial Update...

Suven Life Sciences net profit fell 16.4% YoY to Rs -280 million for the quarter ended June 2024, compared to a loss of Rs 241 million a year ago. Net sales declined 73.5% to Rs 10 million during the period as against Rs 38 million in April-June 2023.

For the year ended March 2024, Suven Life Sciences reported 11.2% increase in net profit to Rs -1,051 million compared to net loss of Rs 1,183 million during FY23. Revenue of the company fell 13.6% to Rs 117 million during FY24.

The current Price to earnings ratio of Suven Life Sciences, based on rolling 12 month earnings, stands at -29.7.


Equitymaster requests your view! Post a comment on "Suven Life Sciences Plunges 4%; BSE HEALTHCARE Index Up 1.0%". Click here!